PISCATAWAY, NJ, June 20, 2005 -- Sabinsa Corporation, a manufacturer and supplier of high quality herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, has launched a new trade advertising campaign for Selenium SeLECT®, its branded L-(+)-Selenomethionine ingredient.  The campaign, which begins running today in select business trade print outlets, features a field of red tulips with a single yellow tulip representing Selenium SeLECT, followed by the tagline 'When the National Cancer Institute began its study of selenium, it could only choose one.'

"This advertising campaign reflects the fact that Selenium SeLECT stands alone in terms of quality, bioavailability and purity in the field of selenium ingredients currently available," stated Hame Persaud, senior vice president of sales and marketing, Sabinsa Corporation.  "We want manufacturers and retailers to know that Selenium SeLECT was chosen by the National Cancer Institute to be used in several of its own studies, which is a testament to the superior quality and efficacy of our material."

Persaud adds, "In addition to this advertisement, which was developed by Integrated Marketing Group as part of a comprehensive marketing campaign, Sabinsa has redesigned www.seleniumselect.com, adding updated information on Selenium SeLECT, as well as recent research findings."

Selenium SeLECT, Sabinsa Corporation's branded L-(+)-Selenomethionine compound, has been shown to be more bioavailable, pure and safe than other forms of selenium. Selenium is a trace mineral that is found naturally in soil and has been shown to have several positive health benefits.  When consumed, selenium enters the body to form selenoproteins and glutathione, the body's antioxidant immune system detoxifier.  Currently, the National Cancer Institute (NCI) is using Selenium SeLECT for its Selenium and Vitamin E Cancer Prevention Trial (SELECT), a 12-year study focused on the role of selenium and vitamin E, both separately and together, in the prevention of
prostate cancer.   Shortly after this study began, the FDA issued a qualified health claim for reducing the risk of certain cancers.

Additionally, NCI is conducting the Prevention of Alzheimer's by Selenium SeLECT and Vitamin E (PREADVISE) trial in conjunction with SELECT.  This study is researching the role of selenium and vitamin E in preventing memory damage with age, including Alzheimer's and other diseases that can affect the brain.  Selenium SeLECT was chosen for these NCI studies because of its exceptional quality.  The worldwide quality standard or USP monograph for selenomethionine is based on Selenium SeLECT.  For more information visit www.seleniumselect.com.

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals.

Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being.  Over the past nine years, Sabinsa has brought to market more than thirty standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products.  With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher.   For more information visit www.sabinsa.com.

# # #